Anti-tubercular treatment-induced granulomatous acute interstitial nephritis.
Journal
Indian journal of pharmacology
ISSN: 1998-3751
Titre abrégé: Indian J Pharmacol
Pays: India
ID NLM: 7902477
Informations de publication
Date de publication:
01 Jul 2024
01 Jul 2024
Historique:
received:
05
01
2024
accepted:
12
08
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
9
9
2024
Statut:
ppublish
Résumé
This case emphasizes the value of meticulous observation and regular follow-up of patients receiving rifampicin therapy. The prognosis for complete improvement in renal function in such cases was excellent, with prompt recognition and discontinuation of rifampicin. Teaching patients about these possible adverse effects and encouraging immediate reporting of signs and symptoms are likely to be beneficial because acute kidney injury can manifest itself very quickly after rifampicin is started. Even if renal failure can happen with any dose of rifampicin, primary physicians must have awareness about patients on intermittent or irregular therapy and those who have previously used this medication. It is challenging to determine the prevalence of adverse reactions to common antibiotics where a state- or country-wide reporting system is absent. Along with withdrawal of the causative agent patients were treated with corticosteroids (0.5-1 mg/kg/day) for an average period of 4-12 weeks showing significant recovery of renal function.
Identifiants
pubmed: 39250627
doi: 10.4103/ijp.ijp_19_24
pii: 01363791-202407000-00009
doi:
Substances chimiques
Rifampin
VJT6J7R4TR
Antitubercular Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
290-292Informations de copyright
Copyright © 2024 Copyright: © 2024 Indian Journal of Pharmacology.
Références
Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin:A study of 25 patients. Am J Kidney Dis 2002;40:690–6.
Nessi R, Bonoldi GL, Redaelli B, di Filippo G. Acute renal failure after rifampicin:A case report and survey of the literature. Nephron 1976;16:148–59.
De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure:Pathophysiologic, immunologic, and clinical features. Am J Kidney Dis 1998;31:108–15.
Schubert C, Bates WD, Moosa MR. Acute tubulointerstitial nephritis related to antituberculous drug therapy. Clin Nephrol 2010;73:413–9.
Hong S, Valderrama E, Mattana J, Shah HH, Wagner JD, Esposito M, et al. Vancomycin-induced acute granulomatous interstitial nephritis:Therapeutic options. Am J Med Sci 2007;334:296–300.